” TB Biosciences’ mission is to create a point-of-care test to replace the 125 year old sputum smear test increasing clinicians’ ability to diagnose and treat those with active Tuberculosis “

  • 2013-07-16_11-27-19
  • 2013-07-16_11-30-32
  • 2013-07-16_11-33-09
  • 2013-07-16_11-34-44
  • 2013-07-16_11-35-43
  • 2013-07-16_11-36-44
  • 2013-07-16_11-38-22

The Company is using a library of small proteins discovered using the genome of TB and present in patients with active Tuberculosis.